Skip to main content
Equibles

UBS Group AG

Position in MESO — Mesoblast Ltd

CIK 1610520 ZURICH, V8
Back to MESO Full portfolio

Position in MESO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,706,715
+$667,744 QoQ
Shares Held
200,053
+50.9% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 72 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 92% Shared 0% None 8%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. MESO ranks #190 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in MESO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,706,715 200,053
2026-03-31 $2,038,971 132,573
2025-12-31 $1,308,979 72,560
2025-09-30 $3,015,902 187,207
2025-06-30 $2,112,517 193,987
2025-03-31 $1,753,375 140,495
2024-12-31 $3,331,408 168,253
2023-12-31 $1,870 1,700
2023-06-30 $4,465 1,142
2023-03-31 $19,029 5,784
2022-12-31 $2,328 800
2022-09-30 $11,013 4,319
2022-06-30 $3,101 1,397
2022-03-31 $7,596 1,800
2021-12-31 $29,620 6,171
2021-09-30 $12,386 2,061
2021-06-30 $13,755 1,839
2021-03-31 $61,222 7,403
2020-12-31 $120,023 14,137
2020-09-30 $276,116 14,853
2020-06-30 $40,183 3,528